Veltassa Coupons & Savings Card – Discount Prices from $1017.67

VELTASSA is used to treat hyperkalemia, a condition characterized by elevated levels of potassium in the blood. It works by binding to potassium in the gastrointestinal tract, which helps to lower potassium levels in the bloodstream.

VELTASSA, also known as patiromer, removes potassium by binding to it in the gastrointestinal tract. This binding occurs primarily in the colon, where VELTASSA exchanges calcium for potassium ions. The bound potassium is then excreted from the body through the feces, thereby lowering the levels of potassium in the blood.

The choice between patiromer and Lokelma (sodium zirconium cyclosilicate) depends on the specific needs and medical condition of the patient. Both medications are used to treat hyperkalemia, but they have different properties and mechanisms of action. Patiromer is often used for chronic management, while Lokelma can be used for both acute and chronic treatment. The decision on which is better should be made by a healthcare provider, considering factors such as the patient's overall health, kidney function, and any other medications they may be taking.

Common side effects of VELTASSA (patiromer) include constipation, diarrhea, nausea, abdominal discomfort, and flatulence. Some patients may also experience low magnesium levels, which can lead to symptoms such as muscle cramps or weakness. It is important for patients to discuss any side effects with their healthcare provider.

Veltassa and Lokelma are not the same, though they are both medications used to treat hyperkalemia, which is a condition characterized by elevated levels of potassium in the blood. Veltassa contains the active ingredient patiromer, while Lokelma contains sodium zirconium cyclosilicate. They work differently to lower potassium levels and may have different dosing regimens and side effect profiles. It is important for patients to follow their healthcare provider's instructions when using these medications.